Nerve growth factor and retinoic acid interactions in the control of small cell lung cancer proliferation

European Journal of Endocrinology

Volumn 147, Issue 3, 2002, Pages 371-379

  Fiorentini, Chiara ^a   Facchetti, Marco ^a   Finardi, Alessandra ^a   Sigala, Sandra ^a   Páez Pereda, Marcelo ^a   Sher, Emanuele ^a   Spano, PierFranco ^a   Missale, Cristina ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; PROTEIN P75; RETINOIC ACID; THYMIDINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER CONTROL; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; IN VIVO STUDY; LUNG SMALL CELL CANCER; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SENSITIVITY ANALYSIS; TIME;

EID: 0036737930     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1470371     Document Type: Article

References (50)

1. Carney DN. Biology of small cell lung cancer. Lancet 1992 339 843-846.
2. Gazdar AF, Helman L, Israel MA, Russell EK, Linnoila RI, Mulshine JL et al. Expression of neuroendocrine cell markers L-dopa decarboxylase, chromogranin A, and dense core granules in human tumors of endocrine and non endocrine origin. Cancer Research 1988 48 4078-4082.
3. Cuttitta F, Carney DN, Mulshine J, Moody TW Fedorko J, Fischler A et al. Bombesine-like peptides can function as autocrine growth factors in human small-cell lung cancer. Nature 1985 316 823-826.
4. Sher E, Pandiella A & Clementi F. Voltage-operated calcium channels in small cell lung carcinoma cell lines: pharmacological, functional and immunological properties. Cancer Research 1990 53 3892-3896.
5. Codignola A, Tarroni P, Clementi F, Pollo A, Lovallo M, Carbone E et al. Calcium channel subtypes controlling serotonin release from human small cell lung carcinoma cell lines. Journal of Biological Chemistry 1993 268 26240-26247.
6. Cattaneo MG, Codignola A, Vicentini LM, Clementi F & Sher E. Nicotine stimulates a serotonergic autocrine loop in human small cell lung carcinoma. Cancer Research 1993 53 5566-5568.
7. Codignola A, Tarroni P, Cattaneo MG, Vicentini LM, Clementi F & Sher E. Serotonin release and cell proliferation are under the control of alpha-bungarotoxin-sensitive nicotinic receptors in small cell lung carcinoma cell lines. FEBS Letters 1994 342 286-290.
8. 3 into the mammotroph phenotype. Endocrinology 1994 135 290-298.
9. Polack M, Scharfmann R, Seilheimer B, Eisenbarth G, Dressler D, Verma IM et al. Nerve growth factor induces neuron-like differentiation of an insulin-secreting pancreatic beta cell line. PNAS 1993 90 5781-5785.
10. Missale C, Boroni F, Losa M, Giovanelli M, Zanellato A, Dal Toso R et al. Nerve growth factor suppresses the transforming phenotype of human prolactinomas. PNAS 1993 90 7961-7965.
11. Paez Pereda M, Missale C, Grubler Y, Arzt E, Schaaf L & Stalla GK. Nerve growth factor and retinoic acid inhibit proliferation and invasion in thyroid tumor cells. Molecular and Cellular Endocrinology 2000 167 99-106.
12. Missale C, Codignola A, Sigala S, Finardi A, Páez-Pereda M, Sher E et al. Nerve growth factor abrogates the tumorigenicity of human small cell lung cancer cell lines. PNAS 1998 95 5366-5371.
13. Kurie JM. The biological basis for the use of retinoids in cancer prevention and treatment. Current Opinions in Oncology 1999 11 497-502.
14. Niles RM. Recent advances in the use of vitamin A (retinoids) in the prevention and treatment of cancer. Nutrition 2000 16 1100-1101.
15. Rodriguez-Tebar A & Rohrer H. Retinoic acid induces NGF-dependent survival response and high-affinity NGF receptors in immature chick sympathetic neurons. Development 1991 112 813-820.
16. Holst A, Rodriguez-Tebar A, Michaille JJ, Dhouailly D, Backstrom A, Ebendal T et al. Retinoic acid-mediated increase in trkA expression is sufficient to elicit NGF-dependent survival of sympathetic neurons. Molecular and Cellular Neuroscience 1995 6 185-198.
17. Haskell BE, Stach RW, Werrbach-Perez K & Perez-Polo JR. Effect of retinoic acid on nerve growth factor receptors. Cell and Tissue Research 1987 247 67-73.
18. Kogner P, Barbany G, Persson H, Soderhall S, Ahstrom L & Bjork O. Expression of nerve growth factor receptor mRNAs and clinical response to retinoic acid in neuroblastoma. Progress in Clinical and Biological Research 1994 385 147-153.
19. Scheibe RJ & Wagner JA. Retinoic acid regulates both expression of the nerve growth factor receptor and sensitivity to nerve growth factor. Journal of Biological Chemistry 1992 267 17611-17616.
20. Johnson DG & Walker CL. Cyclins and cell cycle checkpoints. Annual Reviews of Pharmacology and Toxicology 1999 39 295-312.
21. Lotan R. Retinoids in cancer chemoprevention. FASEB Journal 1996 10 1031-1039.
22. Bertram JS. Inhibition of neoplastic transformation in vitro by retinoids. Cancer Surveillance 1983 3 243-262.
23. Páez Pereda M, Hopfner U, Pagotto U, Renner U, Uhl E, Artz E et al. Retinoic acid stimulates meningioma cell adhesion to the extracellular matrix and inhibits invasion. British Journal of Cancer 1999 81 381-386.
24. Simon D, Koehrle J, Reiners C, Boerner AR, Schmutzler C, Mainz K et al. Redifferentiation therapy with retinoids: therapeutic option for advanced follicular and papillary thyroid carcinoma. World Journal of Surgery 1998 22 569-574.
25. Idres N, Benoit G, Flexor MA, Lanotte M & Chabot GG. Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolites. Cancer Research 2001 61 700-705.
26. McGarvey TW, Silberman S & Persky B. The effect of butyric acid and retinoic acid on invasion and experimental metastasis of murine melanoma cells. Clinical and Experimental Metastasis 1990 8 433-448.
27. Jacob K, Wach F, Holzapfel U, Hein R, Lengyel E, Buettner R et al. In vitro modulation of human melanoma cell invasion and proliferation by all-trans-retinoic acid. Melanoma Research 1998 8 211-219.
28. Toyofuku T, Yabuki M, Otsu K, Kuzuya T, Hori M & Tada M. Direct association of the gap junction protein connexin-43 with ZO-1 in cardiac myocytes. Journal of Biological Chemistry 1998 273 12725-12731.
29. Hossein MZ & Bertram JS. Retinoids suppress proliferation, induce cell spreading, and up-regulate connexin-43 only in post-confluent 10T1/2 cells: implications for the role of gap junctional communication. Cell Growth and Differentiation 1994 5 1253-1261.
30. Gianni M, Ponzanelli L, Mologni L, Reichert U, Rambaldi A, Terao M et al. Retinoid-dependent growth inhibition, differentiation and apoptosis in acute promyelocytic leukemia cells. Expression and activation of caspases. Cell Death and Differentiation 2000 7 447-460.
31. Fujimura S, Suzumiya J, Anzai K, Ohkubo K, Hata T, Yamada Y et al. Retinoic acids induce growth inhibition and apoptosis in adult T-cell leukemia (ATL) cell lines. Leukemia Research 1998 22 611-618.
32. Jetten AM, Nervi C & Vollberg TM. Control of squamous differentiation in tracheobronchial and epidermal epithelial cells: role of retinoids. National Cancer Institute Monographs 1992 13 93-100.
33. Chytil F. Retinoids in lung development. FASEB Journal 1996 10 986-992.
34. Kelloff GJ, Boone CW, Steele VK, Perloff M, Crowell J & Doody LA. Development of chemopreventive agents for lung and upper aero-digestive tract cancers. Journal of Cellular Biochemistry 1993 17 2-17.
35. Moon RC, Mehta RG & Rao KJ. Retinoids and cancer in experimental animals. In The Retinoids, pp 573-595. Eds MB Sporn, AB Roberts & DS Goodman. New York: Raven Press, 1994.
36. Doyle LA, Giangiulo D, Hussain A, Park HJ, Yen RW & Borges M. Differentiation of human variant small cell lung cancer cell lines to a classic morphology by retinoic acid. Cancer Research 1989 49 6745-6751.
37. Kalemkerian GP, Jasti RK, Celano O, Nelkin BD & Mabry M. All-trans-retinoic acid alters myc gene expression and inhibits in vitro progression in small cell lung cancer. Cell Growth and Differentiation 1994 5 55-60.
38. Geradts J, Chen JY, Russel EK, Yankaskas JR, Nieves L & Minna JD. Human lung cancer cell lines exhibit resistance to retinoic acid treatment. Cell Growth and Differentiation 1993 4 799-809.
39. Kim YH, Dohi DF, Han GR, Zou CP, Oridate N, Walsh GL et al. Retinoid refractoriness occurs during lung carcinogenesis despite functional retinoid receptors. Cancer Research 1995 55 5603-5610.
40. Jiang H, Lin J, Su ZZ, Collart FR, Huberman E & Fisher PB. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21WF1/Cip1 expression in the absence of p53. Oncogene 1994 9 3397-3406.
41. Steinman RA, Hoffman B, Iro A, Guillouf C, Lieberman DA & El-Houseini ME. Induction of p21(WAF1/CIP1) during differentiation. Oncogene 1994 9 3389-3396.
42. Poluha W, Poluha DK, Chang B, Crosbie NE, Schonhoff CM, Kilpatrick DL et al. The cyclin-dependent kinase inhibitor p21WAF1 is required for survival of differentiating neuroblastoma cells. Molecular and Cellular Biology 1996 16 1335-1341.
43. Helige C, Smolle J, Zellnig G, Hartmann E, Fink-Puches R, Kerl H et al. Inhibition of K1735-M2 melanoma cell invasion in vitro by retinoic acid. Clinical and Experimental Metastasis 1993 11 409-418.
44. Cartwright M, Martin S, D'Mello S & Heinrich G. The human nerve growth factor gene: structure of promoter region and expression in L929 fibroblasts. Molecular Brain Research 1992 15 67-75.
45. Lancillotti F, Giandomenico V, Affabris E, Fiorucci G, Romeo G & Rossi GB. Interferon alpha-2b and retinoic acid combined treatment affects proliferation and gene expression of human cervical carcinoma cells. Cancer Research 1995 55 3158-3164.
46. Lingen MW, Polverini PJ & Bouck NP. Retinoic acid and interferon alpha act synergistically as antiangiogenic and antitumor agents against human head and neck squamous cell carcinoma. Cancer Research 1998 58 5551-5558.
47. Forman BM, Umesono K, Chen J & Evans RM. Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell 1995 81 541-550.
48. Perlman T & Jansson L. A novel pathway for vitamin A signalling mediated by RXR heterodimerization with NGFI-B and Nurrl. Genes and Development 1995 9 769-782.
49. Lin B, Chen GQ, Xiao D, Kolluri SK, Cao X, Su H et al. Orphan receptor COUP-TF is required for induction of retinoic acid receptor beta, growth inhibition and apoptosis by retinoic acid in cancer cells. Cancer Research 2000 55 3158-3164.
50. Pipaon C., Tsai SY & Tsai MJ. COUP-TF upregulates NGFI-A gene expression through SP1 binding site. Molecular and Cellular Biology 1999 19 2734-2745.